Serum Concentration of Uric Acid Associated With Prehypertension Among Chinese Population

被引:9
作者
Bao, Xundi [1 ]
Wang, Qing [1 ]
Chen, Genwang [1 ]
Wang, Qunan [2 ]
Liang, Ren [3 ]
Zhang, Shunli [4 ]
机构
[1] Anhui Chest Hosp, Hefei, Peoples R China
[2] Anhui Med Univ, Sch Publ Hlth, Hefei, Peoples R China
[3] DAAN Clin Lab Ctr, Hefei, Peoples R China
[4] Natl Ctr Clin Lab, Beijing, Peoples R China
关键词
uric acid; prehypertension; hypertension; JOINT NATIONAL COMMITTEE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; RISK-FACTOR; HYPERURICEMIA; HYPERTENSION; PREVALENCE; PROGRESSION; DISEASE; ADULTS;
D O I
10.1177/0003319713507628
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We evaluated the association between serum uric acid (SUA) levels and prehypertension in a Chinese population. A cross-sectional study was performed during 2008 to 2010, and a total of 11199 participants without hypertension or other cardiovascular diseases (CADs), aged >= 35 years, were available for analysis. After adjusting for age, alcohol consumption, smoking status, body mass index, diabetes, total cholesterol, triglycerides, serum creatinine, the odds ratios (ORs) and 95% confidence intervals (CIs) of the prehypertension from the lowest (referent) to the highest levels of SUA were 1.00 (95% CI, 0.91-1.10), 1.12 (95% CI, 1.03-1.21), 1.17 (95% CI, 1.09-1.27), and 1.25 (95% CI, 1.13-1.39; linear trend P = .002). This association persisted in subgroup analysis by gender and was also consistent with separate analysis by classification of age, smoking status, alcohol usage, overweight, and diabetes mellitus. Independent of other cardiovascular risk factors, higher SUA levels are positively associated with prehypertension in a Chinese population without hypertension and CADs. Prospective trials should evaluate interventions that lower the SUA levels.
引用
收藏
页码:800 / 805
页数:6
相关论文
共 32 条
[1]  
Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37
[2]   Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study [J].
Chien, KL ;
Hsu, HC ;
Sung, FC ;
Su, TC ;
Chen, MF ;
Lee, YT .
ATHEROSCLEROSIS, 2005, 183 (01) :147-155
[3]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[4]   FLOATING ABSOLUTE RISK - AN ALTERNATIVE TO RELATIVE RISK IN SURVIVAL AND CASE-CONTROL ANALYSIS AVOIDING AN ARBITRARY REFERENCE GROUP [J].
EASTON, DF ;
PETO, J ;
BABIKER, AGAG .
STATISTICS IN MEDICINE, 1991, 10 (07) :1025-1035
[5]   Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992 [J].
Fang, J ;
Alderman, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2404-2410
[6]   Hyperuricemia in childhood primary hypertension [J].
Feig, DI ;
Johnson, RJ .
HYPERTENSION, 2003, 42 (03) :247-252
[7]   Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle [J].
Hayden M.R. ;
Tyagi S.C. .
Nutrition & Metabolism, 1 (1)
[8]   Resurrection of uric acid as a causal risk factor in essential hypertension [J].
Johnson, RJ ;
Feig, DI ;
Herrera-Acosta, J ;
Kang, DH .
HYPERTENSION, 2005, 45 (01) :18-20
[9]   Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? [J].
Johnson, RJ ;
Kang, DH ;
Feig, D ;
Kivlighn, S ;
Kanellis, J ;
Watanabe, S ;
Tuttle, KR ;
Rodriguez-Iturbe, B ;
Herrera-Acosta, J ;
Mazzali, M .
HYPERTENSION, 2003, 41 (06) :1183-1190
[10]   Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cells [J].
Kang, DH ;
Park, SK ;
Lee, IK ;
Johnson, RJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (12) :3553-3562